Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Dynavax Technologies (DVAX)

Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,490,860
  • Shares Outstanding, K 130,892
  • Annual Sales, $ 232,280 K
  • Annual Income, $ -6,390 K
  • 60-Month Beta 1.30
  • Price/Sales 6.68
  • Price/Cash Flow N/A
  • Price/Book 2.41
Trade DVAX with:

Options Overview Details

View History
  • Implied Volatility 33.81% ( +0.62%)
  • Historical Volatility 33.64%
  • IV Percentile 17%
  • IV Rank 29.11%
  • IV High 63.24% on 12/07/23
  • IV Low 21.73% on 05/10/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 72
  • Volume Avg (30-Day) 475
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 9,831
  • Open Int (30-Day) 11,363

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.06
  • Number of Estimates 3
  • High Estimate 0.10
  • Low Estimate 0.03
  • Prior Year 0.03
  • Growth Rate Est. (year over year) +100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.48 +9.73%
on 05/09/24
12.06 -4.68%
on 05/01/24
+0.29 (+2.59%)
since 04/26/24
3-Month
10.48 +9.73%
on 05/09/24
13.27 -13.31%
on 03/08/24
-1.45 (-11.20%)
since 02/28/24
52-Week
10.48 +9.73%
on 05/09/24
15.15 -24.09%
on 11/03/23
+0.30 (+2.68%)
since 05/26/23

Most Recent Stories

More News
Dynavax Technologies (DVAX) Q1 2024 Earnings Call Transcript

DVAX earnings call for the period ending March 31, 2024.

DVAX : 11.50 (+0.97%)
Dynavax Technologies: Q1 Earnings Snapshot

Dynavax Technologies: Q1 Earnings Snapshot

DVAX : 11.50 (+0.97%)
Dynavax Technologies (DVAX) Q4 2023 Earnings Call Transcript

DVAX earnings call for the period ending December 31, 2023.

DVAX : 11.50 (+0.97%)
Why Vera Therapeutics Stock Soared by 22% This Week

Executive changes and a bullish analyst take combined to boost sentiment on the company.

AMGN : 300.19 (-1.85%)
DVAX : 11.50 (+0.97%)
VERA : 37.13 (+0.05%)
Dynavax Technologies (DVAX) Q3 2023 Earnings Call Transcript

DVAX earnings call for the period ending September 30, 2023.

DVAX : 11.50 (+0.97%)
Dynavax Technologies: Q3 Earnings Snapshot

Dynavax Technologies: Q3 Earnings Snapshot

DVAX : 11.50 (+0.97%)
Dynavax to Present at the H.C. Wainwright 4th Annual Hepatitis B Virus Virtual Conference

/PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative...

DVAX : 11.50 (+0.97%)
Dynavax to Present at the H.C. Wainwright 25th Annual Global Investment Conference

/PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative...

DVAX : 11.50 (+0.97%)
Dynavax Technologies (DVAX) Q2 2023 Earnings Call Transcript

DVAX earnings call for the period ending June 30, 2023.

DVAX : 11.50 (+0.97%)
Dynavax Technologies: Q2 Earnings Snapshot

Dynavax Technologies: Q2 Earnings Snapshot

DVAX : 11.50 (+0.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development...

See More

Key Turning Points

3rd Resistance Point 11.85
2nd Resistance Point 11.69
1st Resistance Point 11.59
Last Price 11.50
1st Support Level 11.33
2nd Support Level 11.17
3rd Support Level 11.07

See More

52-Week High 15.15
Fibonacci 61.8% 13.37
Fibonacci 50% 12.81
Fibonacci 38.2% 12.26
Last Price 11.50
52-Week Low 10.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar